185 related articles for article (PubMed ID: 11577369)
1. [Intravenous immunoglobulins in the prevention of infection in children with hematologic-oncologic diseases].
Lehrnbecher T
Klin Padiatr; 2001 Sep; 213 Suppl 1():A103-5. PubMed ID: 11577369
[TBL] [Abstract][Full Text] [Related]
2. [Hematopoietic growth factors in the prevention of infections complications in children with hematologic-oncologic diseases].
Lehrnbecher T
Klin Padiatr; 2001 Sep; 213 Suppl 1():A88-102. PubMed ID: 11577368
[TBL] [Abstract][Full Text] [Related]
3. [Importance of prevention of infectious complications in pediatric hematologic-oncologic patients].
Fleischhack G; Simon A
Klin Padiatr; 2001 Sep; 213 Suppl 1():A5-8. PubMed ID: 11577360
[TBL] [Abstract][Full Text] [Related]
4. [Hematopoietic growth factors in prophylaxis and therapy of infections complications in children with neutropenia].
Lehrnbecher T
Klin Padiatr; 2001; 213(4):212-38. PubMed ID: 11528556
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin: use in pediatric bone marrow transplantation.
Casper JT; Sedmak G; Harris RE; Carrigan DR; Baxter-Lowe LA; Ash RC
Semin Hematol; 1992 Jul; 29(3 Suppl 2):100-5. PubMed ID: 1324528
[No Abstract] [Full Text] [Related]
6. [Vaccination].
Graubner UB; Liese J; Belohradsky BH
Klin Padiatr; 2001 Sep; 213 Suppl 1():A77-83. PubMed ID: 11577366
[TBL] [Abstract][Full Text] [Related]
7. [Polyvalent immunoglobulins in prevention of viral infections in children with neoplastic diseases treated with immunosuppressive therapy].
Graf N; Hille A; Jost W; Müller J
Padiatr Padol; 1991; 26(4):187-91. PubMed ID: 1749627
[TBL] [Abstract][Full Text] [Related]
8. [Antiviral prophylaxis].
Graubner UB
Klin Padiatr; 2001 Sep; 213 Suppl 1():A69-76. PubMed ID: 11577365
[TBL] [Abstract][Full Text] [Related]
9. The role of immunoglobulin in bone marrow transplantation.
Saral R
Transplant Proc; 1991 Aug; 23(4):2128-32. PubMed ID: 1871829
[TBL] [Abstract][Full Text] [Related]
10. [Antimicrobial prophylaxis of bacterial infections in pediatric oncology patients].
Simon A; Fleischhack G; Marklein G; Ritter J
Klin Padiatr; 2001 Sep; 213 Suppl 1():A22-37. PubMed ID: 11577362
[TBL] [Abstract][Full Text] [Related]
11. [Immunoglobulins and rules of passive-active prophylaxis].
Bucholc B
Przegl Epidemiol; 2003; 57(2):391-7. PubMed ID: 12910611
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of fungal infections in children and adolescents with cancer].
Groll AH; Ritter J; Müller FM
Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic and therapeutic use of immunoglobulin for intravenous administration in patients with secondary immunodeficiencies associated with malignancies.
Morell A; Barandun S
Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S87-91. PubMed ID: 2840630
[TBL] [Abstract][Full Text] [Related]
14. Randomized double-blinded comparison of three intravenous immunoglobulin products in bone marrow transplantation.
Peltier MK; Filipovich AH; Bechtel M; Dirksen CL; Englund JA
Semin Hematol; 1992 Jul; 29(3 Suppl 2):112-5. PubMed ID: 1324529
[TBL] [Abstract][Full Text] [Related]
15. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
[TBL] [Abstract][Full Text] [Related]
16. New approaches to the prophylaxis and treatment of bacterial and fungal infections in allogeneic marrow transplant recipients.
Schuler U; Ehninger G
Bone Marrow Transplant; 1994; 14 Suppl 4():S61-5. PubMed ID: 7728128
[TBL] [Abstract][Full Text] [Related]
17. [Infectious complications following hematopoietic stem cell transplantation].
Akiyama H
Rinsho Ketsueki; 2008 Aug; 49(8):576-82. PubMed ID: 18800605
[No Abstract] [Full Text] [Related]
18. Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 cases.
Krüger W; Rüssmann B; Kröger N; Salomon C; Ekopf N; Elsner HA; Kaulfers PM; Mack D; Fuchs N; Dürken M; Kabisch H; Erttmann R; Zander AR
Bone Marrow Transplant; 1999 Mar; 23(6):589-97. PubMed ID: 10217190
[TBL] [Abstract][Full Text] [Related]
19. Special considerations for the patient undergoing allogeneic or autologous bone marrow transplantation.
Hiemenz JW; Greene JN
Hematol Oncol Clin North Am; 1993 Oct; 7(5):961-1002. PubMed ID: 8226568
[TBL] [Abstract][Full Text] [Related]
20. Some but not all benefits of intravenous immunoglobulin therapy after marrow transplantation appear to correlate with IgG trough levels.
Cottler-Fox M; Lynch M; Pickle LW; Cahill R; Spitzer TR; Deeg HJ
Bone Marrow Transplant; 1991 Jul; 8(1):27-33. PubMed ID: 1655138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
